{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T05:34:48Z","timestamp":1738474488444,"version":"3.35.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","elsevier.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.reumae.2025.101799","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T19:47:58Z","timestamp":1738352878000},"page":"101799","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiovascular risk in patients with osteoporosis within a Rheumatology setting. Results from a Spanish survey-based multicenter study"],"prefix":"10.1016","volume":"21","author":[{"given":"Enrique","family":"Casado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"G\u00f3mez-Olmedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reumae.2025.101799_bib0155","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11657-020-00871-9","article-title":"SCOPE 2021: a new scorecard for osteoporosis in Europe","volume":"16","author":"Kanis","year":"2021","journal-title":"Arch Osteoporos"},{"key":"10.1016\/j.reumae.2025.101799_bib0160","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.2147\/TCRM.S138000","article-title":"A comprehensive overview on osteoporosis and its risk factors","volume":"14","author":"Pouresmaeili","year":"2018","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.reumae.2025.101799_bib0165","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0002-9343(99)00028-5","article-title":"The association between low bone mass at the menopause and cardiovascular mortality","volume":"106","author":"von der Recke","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.reumae.2025.101799_bib0170","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nrrheum.2012.120","article-title":"Osteoporosis \u2013 a risk factor for cardiovascular disease?","volume":"8","author":"Lampropoulos","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.reumae.2025.101799_bib0175","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3109\/09513590.2015.1041908","article-title":"Osteoporosis and cardiovascular disease: an update","volume":"31","author":"Lello","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.reumae.2025.101799_bib0180","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2298\/SARH1502028T","article-title":"Osteoporosis \u2013 a risk factor for cardiovascular diseases: a follow-up study","volume":"143","author":"Tasic","year":"2015","journal-title":"Srp Arh Celok Lek"},{"key":"10.1016\/j.reumae.2025.101799_bib0185","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1136\/heartjnl-2020-318764","article-title":"Prognostic value of lower bone mineral density in predicting adverse cardiovascular disease in Asian women","volume":"107","author":"Park","year":"2021","journal-title":"Heart"},{"key":"10.1016\/j.reumae.2025.101799_bib0190","doi-asserted-by":"crossref","first-page":"977082","DOI":"10.3389\/fcvm.2022.977082","article-title":"The association between heart failure and risk of fractures: pool analysis comprising 260,410 participants","volume":"9","author":"Liu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.reumae.2025.101799_bib0195","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.mayocp.2021.07.019","article-title":"Osteoporosis and its association with cardiovascular disease, respiratory disease, and cancer: findings from the UK Biobank Prospective Cohort Study","volume":"97","author":"Rodriguez-Gomez","year":"2022","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.reumae.2025.101799_bib0200","unstructured":"WHO. Cardiovascular diseases (CVDs). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds) [accessed 08.01.24]."},{"key":"10.1016\/j.reumae.2025.101799_bib0205","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1359\/JBMR.050711","article-title":"Relationship between osteoporosis and cardiovascular disease in postmenopausal women","volume":"20","author":"Tank\u00f3","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.reumae.2025.101799_bib0210","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.amjcard.2005.12.033","article-title":"Comparison of prevalence of atherosclerotic vascular disease in postmenopausal women with osteoporosis or osteopenia versus without osteoporosis or osteopenia","volume":"97","author":"Ness","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.reumae.2025.101799_bib0215","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1365-2796.2006.01640.x","article-title":"Radiographic measure of aorta calcification is a site-specific predictor of bone loss and fracture risk at the hip","volume":"259","author":"Bagger","year":"2006","journal-title":"J Intern Med"},{"key":"10.1016\/j.reumae.2025.101799_bib0220","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/1759720X11430858","article-title":"Aging and bone loss: new insights for the clinician","volume":"4","author":"Demontiero","year":"2012","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.reumae.2025.101799_bib0225","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0531-5565(99)00029-7","article-title":"Age-related changes in vascular responses","volume":"34","author":"Marin","year":"1999","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.reumae.2025.101799_bib0230","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/GME.0000000000001831","article-title":"Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society","volume":"28","year":"2021","journal-title":"Menopause"},{"key":"10.1016\/j.reumae.2025.101799_bib0235","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/1559827618812395","article-title":"Lifestyle strategies for risk factor reduction, prevention, and treatment of cardiovascular disease","volume":"13","author":"Rippe","year":"2019","journal-title":"Am J Lifestyle Med"},{"key":"10.1016\/j.reumae.2025.101799_bib0240","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20235867","article-title":"Osteoporosis in rheumatic diseases","volume":"20","author":"Adami","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.reumae.2025.101799_bib0245","doi-asserted-by":"crossref","first-page":"101614","DOI":"10.1016\/j.beem.2022.101614","article-title":"Regulation of bone mass in endocrine diseases including diabetes","volume":"36","author":"Higham","year":"2022","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.reumae.2025.101799_bib0250","doi-asserted-by":"crossref","first-page":"11177","DOI":"10.1038\/s41598-022-15248-w","article-title":"The relationship between osteoporosis and depression","volume":"12","author":"Kashfi","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.reumae.2025.101799_bib0255","article-title":"Skeletal consequences of heart failure","volume":"18","author":"Bandeira","year":"2022","journal-title":"Womens Health (Lond)"},{"key":"10.1016\/j.reumae.2025.101799_bib0260","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jbspin.2016.09.022","article-title":"Osteoporosis and ischemic cardiovascular disease","volume":"84","author":"Laroche","year":"2017","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.reumae.2025.101799_bib0265","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/MAJ.0b013e3181db6dfe","article-title":"Effects of treatment with risedronate and alfacalcidol on progression of atherosclerosis in postmenopausal women with type 2 diabetes mellitus accompanied with osteoporosis","volume":"339","author":"Kanazawa","year":"2010","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.reumae.2025.101799_bib0270","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bone.2013.12.017","article-title":"Effects of intravenous zoledronate and ibandronate on carotid intima-media thickness, lipids and FGF-23 in postmenopausal osteoporotic women","volume":"61","author":"Gonnelli","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.reumae.2025.101799_bib0275","doi-asserted-by":"crossref","first-page":"e0122646","DOI":"10.1371\/journal.pone.0122646","article-title":"Bisphosphonates and risk of cardiovascular events: a meta-analysis","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.reumae.2025.101799_bib0280","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1001\/jama.281.23.2189","article-title":"The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation","volume":"281","author":"Cummings","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.reumae.2025.101799_bib0285","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1359\/jbmr.080710","article-title":"Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial","volume":"23","author":"Silverman","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.reumae.2025.101799_bib0290","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.reumae.2025.101799_bib0295","article-title":"Romosozumab for the treatment of osteoporosis in women: efficacy, safety, and cardiovascular risk","volume":"18","author":"Lim","year":"2022","journal-title":"Womens Health (Lond)"},{"key":"10.1016\/j.reumae.2025.101799_bib0300","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s00198-022-06413-y","article-title":"Comparative effectiveness and cardiovascular safety of abaloparatide and teriparatide in postmenopausal women new to anabolic therapy: a US administrative claims database study","volume":"33","author":"Cosman","year":"2022","journal-title":"Osteoporos Int"}],"container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574325000115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574325000115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T03:17:00Z","timestamp":1738466220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173574325000115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2173574325000115"],"URL":"https:\/\/doi.org\/10.1016\/j.reumae.2025.101799","relation":{},"ISSN":["2173-5743"],"issn-type":[{"type":"print","value":"2173-5743"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular risk in patients with osteoporosis within a Rheumatology setting. Results from a Spanish survey-based multicenter study","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reumae.2025.101799","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101799"}}